Science Strategic Acquisition Equity Alpha Warrant Exp 20 Jan 2026 *W EXP 01/20/2026
Change company Symbol lookup
Select an option...
SSAAW Science Strategic Acquisition Equity Alpha Warrant Exp 20 Jan 2026 *W EXP 01/20/2026
WETF Wisdom Tree Investments Inc
CYTHW Cyclo Therapeutics Equity Warrants Exp 14th Nov 2025 *W EXP 12/11/2025
FR First Industrial Realty Trust Inc
PNI PIMCO New York Municipal Income Fund II
NIB iPath? Bloomberg Cocoa Subindex Total Return(SM) ETN
DG Dollar General Corp
SPCO Stephan Co
KEX Kirby Corp
GM General Motors Co
Go

Company profile

Science Strategic Acquisition Corp. Alpha is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. It intends to focus on sectors, including direct-to-consumer (D2C) brands, D2C services & marketplaces and mobile & social entertainment. It neither engages in any operations nor generates any revenues.

Closing Price
$0.0601
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
0.0601
Day's Low
0.0598
Volume
(Average)
Volume:
9,205

10-day average volume:
21,085
9,205

Aurora Cannabis ups financing deal to $150 mln, shares fall

9:39 am ET May 27, 2022 (MarketWatch)
Print

Aurora Cannabis Inc. (ACB.T) shares dropped 28% Friday after the cannabis company said it would increase the size of its bought deal financing to $150 million from $125 million. A syndicate of underwriters led by Canaccord Genuity and BMO Capital Markets will buy on a bought deal basis 61.2 million units of the company at a price of $2.45 per unit for gross proceeds of approximately $150 million. Each Unit will be comprised of one common share and one common share purchase warrant exercisable for 36 months following the closing date of the offering at an exercise price of $3.20 per warrant share. Aurora said the money will be used for general corporate purposes. Aurora Cannabis shares have lost 63% of their value this year, compared to a 41.9% loss by the Cannabis ETF (THCX).

-Steve Gelsi

	

(END) Dow Jones Newswires

May 27, 2022 09:39 ET (13:39 GMT)

Copyright (c) 2022 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.